Edgewise Therapeutics Inc (EWTX) — Cash Flow Quality Index

Latest as of December 2025: -0.33x

Edgewise Therapeutics Inc (EWTX) has a Cash Flow Quality Index of -0.33x as of December 2025. Operating cash flow of $-38.59 Million is below net income of $117.58 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore debt repayment capacity of Edgewise Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-0.33x

Operating CF / Net Income

Operating Cash Flow

$-38.59 Million

USD

Net Income

$117.58 Million

USD

Data as of

Dec 2025

Most recent filing

Annual Cash Flow Quality Index for Edgewise Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Edgewise Therapeutics Inc.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.